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g.2012.0Abstract Congenital heart diseases (CHDs) are the most common of all birth defects. Congenital
heart disease may occur as an isolated malformation or may be part of a syndrome. One of the most
common syndromes associated with CHDs is the 22q11.2 microdeletion syndrome, the various con-
ditions associated with del22q11 include DiGeorge syndrome (DGS), velocardiofacial syndrome
(VCFS), conotruncal anomaly face syndrome (CTAFS), and others. The abnormalities associated
with this syndrome include parathyroid hypoplasia, thymic hypoplasia, immune defect, cleft palate,
and abnormal facies. The cardiac defects are usually derived from conotruncus.
The aim of the study was to detect the prevalence and the most common or frequent clinical man-
ifestations of chromosome 22q11.2 microdeletion among children with syndromic congenital heart
disease.
The study was conducted on 20 children with syndromic CHD presenting to the Menouﬁya
University Hospitals, Egypt. Their ages ranged from 10 days to 12 years. Cytogenetic study and
ﬂuorescence in situ hybridization (FISH) were performed in the patients. The study revealed that
2 patients were with chromosomal aberrations [one with 46,XY, add (13)(p13) & the other with
47,XX,+13]. In addition, FISH revealed 4 patients (20%) with 22q11.2 microdeletion syndrome.exandria, Egypt. Tel.: +20
(M.A.M. Tawﬁk).
Shams University.
g by Elsevier
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314 S.S.A. El-Ella et al.The congenital heart malformations detected in patients with 22q11.2 microdeletion were somewhat
unexpected and included VSD, ASD, PDA, and double outlet right ventricle. The most frequent
extracardiac features were hypocalcemia, microcephaly, brain atrophy, epicanthus, low set posteri-
orly rotated ears, micrognathia, and anemia. The extracardiac features were in some cases subtle.
It is concluded that 22q11.2 microdeletion is not uncommon and its manifestations are highly
variable. This entails that screening for the microdeletion by FISH should be performed in all
patients with syndromic CHD especially those with hypocalcemia, microcephaly, brain atrophy,
epicanthus, low set ears, posteriorly rotated ears, micrognathia, and anemia. In addition, patients
with minor features and those with non-conotruncal heart disease should not be excluded from the
screening for 22 microdeletion.
 2012 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Congenital heart disease (CHD) affects about 1% of newborn
children and is the leading cause of death in infants under
1 year of age [1]. In most patients, CHDs may be isolated
but about 33% have associated anomalies (syndromic CHD).
One of the most common syndromes associated with CHD is
22q11.2 microdeletion syndrome [2].
22q11DS is the most common microdeletion syndrome in
man [3] with a minimum prevalence rate of one in 4000 live
births [4].
Thephenotypeof 22q11DSencompassesDiGeorge syndrome
(cardiac anomalies, hypoparathyroidism, immunodeﬁciency),
velocardiofacial syndrome (VCFS) (pharyngeal dysfunction,
cardiac anomaly, dysmorphic facies) [5], Conotruncal anomaly
face syndromes [6], Cayler Cardiofacial syndrome (asymmetric
crying facies) [7,8], CHARGE syndrome (coloboma, heart de-
fects, atresia of the choanae, retardation of growth, genitouri-
nary problems and ear abnormalities) [9], and autosomal
dominant Opitz G/BBB syndrome (Hypertelorism-Hypospa-
dias syndrome) [10].
Over 180 clinical features have been associated with VCFS
but there is no single ﬁnding or group of ﬁndings that occur in
all affected individuals. Cardinal features that raise diagnostic
suspicion in newborns include cleft palate when seen with
conotruncal heart defects, especially if accompanied by hypo-
calcemia [11].
Approximately 75% of patients with 22q11DS have CHD,
typically involving the conotruncus and include lesions such as
Tetralogy of Fallot and truncus arteriosus. Associated anoma-
lies of the aortic arch, ductus arteriosus, and pulmonary arter-
ies are more frequent in these patients [12].
Characteristic facial features include increased vertical
length of the face, distinctive nasal conﬁguration, hooded eye-
lids, hypertelorism, ear abnormalities, and retrognathia. The
nasal root is prominent with a broad or ‘‘tubular’’ midportion,
bulbous tip, and hypoplastic alae nasae. Asymmetric crying fa-
cies, craniosynostosis, and ﬂat malar eminences are also seen
[11].
Hypocalcemia, due to hypoparathyroidism and a variably
severe immune deﬁciency due to thymic hypoplasia [13] are
characteristic features of 22q11.2 DS.
Other clinical manifestations of 22q11.2 DS include
abnormalities of the palate (such as cleft palate and velopha-
ryngeal incompetence), eye, ear, nose, respiratory tract, gen-
itourinary system, and the skeletal system. 22q11.2 DS canalso involve the nervous system with variable effects on
behavior, psychosocial development and cognitive function,
and speech.
22q11.2 microdeletion has also been implicated in isolated
non-syndromic CHD [12]. However, caution should be taken
before stating a causal relationship between del22 and isolated
CHDs because the phenotypical expression of 22q11.2 DS is
extremely variable and the analysis of large series from the lit-
erature shows that patients with CHD and del22 always pres-
ent one or more additional phenotypical anomaly of the
syndrome [14].
The aim of this study is to detect the prevalence and clinical
manifestations of chromosome 22q11.2 microdeletion among
children with syndromic congenital heart disease.2. Patients and methods
2.1. Patients
The study was conducted on 20 children with syndromic con-
genital heart disease, i.e. congenital heart disease with at least
one extracardiac anomaly, they were selected from the Meno-
uﬁya University Hospitals, Egypt, during the period from 2007
to 2009.
Exclusion criteria: Patients with CHD associated with
known environmental risk factors, e.g. maternal diabetes were
excluded from the study. Likewise, patients with well known
syndromes, e.g. Down syndrome were excluded.
2.2. Methods
All studied patients (after having written informed consents
from parents) were subjected to the following: A detailed his-
tory, thorough clinical examination and laboratory investiga-
tions including complete blood picture, serum calcium and
genetic studies. Radiological investigations included chest
X-ray and pelvicabdominal ultrasonography. Speciﬁc investi-
gations were ordered for each case as needed.
All patients were subjected to a high resolution cytogenetic
study using G-banding and ﬂuorescence in situ hybridization
(FISH).
FISH technique was performed using a ﬂuorophore labeled
locus speciﬁc identiﬁer (LSI) TUPLE1 (HIRA) probe/ARSA
(Arylsulfatase A) dual color DNA probe which hybridizes to
band 22q11.2 of chromosome 22 (LSI TUPLE Spectrum
Table 1 Demographic data of the studied group.
Variable No. % Range Median Mean
Age – – 10 days–12 years 1 year 22.7 months
Sex
Male 9 45 – – –
Female 11 55 – – –
Gestational age
Preterm 1 5 –- – –
Full term 19 95 – – –
Post term 0 0 – – –
Birth weight for gestational age
SGA* 8 40 – – –
AGA** 12 60 – – –
LGA*** 0 0 – – –
* Small for gestational age.
** Appropriate for gestational age.
*** Large for gestational age.
Table 3 Anthropometric measurements of the studied group.
Weight Length Head circumference
No. % No. % No. %
<3rd percentile 12 60 12 60 13 65
>97th percentiles 0 0 0 0 1 5
Normal percentiles 8 40 8 40 6 30
Chromosome 22 in syndromic congenital heart disease 315Orange) and to band 22q13 (ARSA Spectrum Green) of chro-
mosome 22. The hybridized probe ﬂuoresces with moderate to
bright intensity both in interphase nuclei and on metaphase
chromosomes. In interphase nuclei of normal cells, the probe
generally appears as 2 distinct orange signals and a distinct
green signal. The ARSA is speciﬁc to the 22q13 band that
maps very close to the telomeric end of chromosome 22 and
is directly labeled with spectrum green and it is used as an
internal control and also to evaluate 22q13 as doses of green.
The probe was hybridized to metaphase and interphase cells.
The absence of the orange pink signal on chromosome 22 indi-
cates deletion of the TUPLE1 locus at 22q11.2.
3. Results
The results of this study are illustrated in Tables 1–9 and Figs.
1–5.
The study included 20 patients. Their ages ranged from
10 days to 12 years with a mean of 22.7 months. Nine casesTable 2 Family history of the studied group.
No.
Consanguinity
+ve 4
ve 16
Parental age
Maternal age (y) –
Paternal age (y) –
Maternal age groups
Young age (<20 years) 0
Middle age (20–34 years) 18
Old age (P35 years) 2
Medical history of the family
History of congenital heart disease 0
History of other congenital anomalies 4
History of motor or mental handicaps 10
History of sib death 2
Obstetric history
Abortion 5
Preterm labor 0
Still birth 1(45%) were males and 11 (55%) were females. Only one case
(5%) was preterm. Eight cases (40%) were small for gesta-
tional age (SGA) whereas 60% were appropriate for gesta-
tional age (AGA). No patient was large for gestational age
(LGA) Table 1.
Family history (Table 2) revealed that consanguinity was
positive in 4 cases (20%). Maternal age ranged from 20 to
38 years with a mean of 27.1 ± 4.24 years. Paternal age ranged
from 25 to 45 years with a mean of 34.25 ± 5.35 years. Only 2
women (10%) were of old age (P35 years) while the majority
(90%) were of middle age (20–34 years). No mother had a
young age (<20 years). There was no family history of con-
genital heart disease in our study group. History of other con-
genital anomalies was present in 20% of cases. These included
myelomeningocele, an unknown lung anomaly, and polydac-
tyly in 2 cases (10%). Family history of motor or mental hand-
icap was present in 50% of cases. History of sib death was
present in 2 cases (10%). Maternal history of abortion was
present in 25% of cases. History of stillbirth was present in
one case (5%). No history of preterm labor was reported.
Anthropometric measurements of patients showed that
60% of patients had weights below the 3rd percentiles. Sixty
percent of children had short stature (all were proportionate).
Sixty-ﬁve percent of children had a small head circumference
(less than the 3rd percentiles). Thirty percent of children had
normal head circumference and only one child (5%) had a
large head circumference (Table 3).
As to the type of congenital heart disease in our study
group, VSD, pulmonary stenosis, PDA, and ASD plus VSD% Range Mean SD
20 – – –
80 – – –
– 20–38 27.1 4.24
– 25–45 34.25 5.35
0 – – –
90 – – –
10 – – –
0 – – –
20 – – –
50 – – –
10 – – –
25 – – –
0 – – –
5 – – –
Table 4 Types and prevalence of CHD among patients.
Type of CHD No. %
VSD 2 10
Pulmonary stenosis (PS) 2 10
PDA 2 10
ASD+ VSD 2 10
Fallot tetralogy 1 5
Subvalvular aortic stenosis 1 5
Double outlet right ventricle 1 5
PDA+ 2 ASDs 1 5
VSD+ Coarctation of aorta 1 5
ASD+ PS+ Coarctation of aorta 1 5
Fallot tetralogy + PDA+ 2 ASDs 1 5
Tricuspid atresia + VSD+ASD+ PS 1 5
Supravalvular aortic stenosis + ASD+ branch pulmonary stenosis 1 5
ASD+ inlet VSD+ outlet VSD+ pulmonary atresia + hypoplastic pulmonary
arteries + right sided aortic arch + complete atrioventricular septal defect
1 5
Shone complex (Coarctation of aorta, subvalvular AS, parachute mitral valve) + thickened
tricuspid valve leaﬂets with abnormal insertion of its septal leaﬂet
1 5
ASD+ Aortic regurgitation + mitral regurgitation + non-compaction of the left ventricle 1 5
Total 20 100
Table 5 Results of karyotype analysis in the studied group.
Karyotype No. %
Normal
Male (46,XY) 8 40
Female (46,XY) 10 50
Abnormal
Numerical 47, XX,+13 (trisomy13) 1 5
Structural 46,XY, add (13)(p13) 1 5
Total 20 100
Table 6 Prevalence of chromosome 22 microdeletion, by
FISH technique, among all patients with syndromic CHD.
No. %
Chromosome 22 microdeletion by FISH 4 20
Normal chromosome 22 by FISH 14 70
Chromosome 22 not tested by FISH 2 10
Total 20 100
316 S.S.A. El-Ella et al.were the most common types; each existed in 2 cases (10%)
(Table 4).
High resolution cytogenetic study revealed that 8 patients
(40%) had a normal male karyotype (46, XY) while 10 patients
(50%) had normal female karyotype (46, XX). The third pa-
tient had a numerical chromosomal aberration in the form
of trisomy 13 (47, XX,+13). The ﬁfth patient had a structural
chromosomal aberration in the form of 46, XY, add (13)(p13)
(Table 5 and Fig. 1A and B).
These two patients with chromosomal aberrations on con-
ventional cytogenetic study were excluded from FISH study.
FISH study revealed that 4 patients (20%) had chromosome
22 microdeletion while 14 patients (70%) had normal chromo-
some 22 (Table 6).
The ages of our patients with 22 microdeletion ranged from
2.5 months to 5 years. They were 3 females and 1 male. They
were all full term with normal birth weight. Consanguinity
was negative in all cases and there was no family history of
CHD. However, family history of genetic disease or develop-
mental delay was present in 3 cases. History of abortion was
reported in only 1 patient’s mother (Table 7).
The cardiac defects in patients with 22q11.2 microdeletion
included PDA, VSD, and double outlet right ventricle, and
ASD plus PDA (Table 8).
The most frequent extracardiac features in patients with
22q11.2 DS were hypocalcemia, microcephaly, brain atrophy,epicanthus, low set ears, micrognathia, posteriorly rotated
ears, and anemia. These features occurred in 75% of cases.
Less frequent features (occurred in 50% of cases) were delayed
motor and mental milestones, upward slanting palpebral ﬁs-
sure, recurrent seizures, hypertelorism, attached ear lobule,
anteverted nostrils, PDA, and lymphopenia. Most features oc-
curred in only one patient (25%). These included decreased
weight and decreased length, agenesis of the corpus callosum,
absent septum pellucidum, asymmetric crying face, malar ﬂat-
tening, broad forehead, deep set eyes, triangular face, partial
synophrys, hooding of the eyelids, antimongoloid slant, nar-
row palpebral ﬁssure, arched eyebrows, broad nasal bridge, de-
pressed nasal bridge, hypoplastic ala nasi, skin tag on the helix,
short vertical diameter of ears, umbilical hernia, epigastric her-
nia, anal stenosis, microstomia, dental caries, delayed teeth
eruption, laryngeal web, simian crease, camptodactyly of 5th
ﬁnger, and tapering ﬁngers (Table 9 and Fig. 4).
It is to be noted that all patients with 22q11.2 microdeletion
had normal thymic shadow on X-ray.
4. Discussion
Over the past decade, there have been major breakthroughs in
the understanding of inherited causes of CCVDs, including the
identiﬁcation of speciﬁc genetic abnormalities for some types
of malformations [15].
Many patients with CHD are managed as just ‘‘cardiac
cases’’, though their cardiac disease may be nothing but the
Table 7 Demographic and historical data of patients with 22q11.2 microdeletion.
Serial
no.
Age Sex Gestational
age
Birth
weight
Consan-
guinity
Maternal
age
Paternal
age
Family
history
of CHD
Family history
of genetic diseases
or developmental delay
Obstetric
history
2 2.5 months F Full term Normal ve 28 y 30 y ve +ve (3 cousins had mild
mental retardation
ve
6 5 years F Full term Normal ve 35 y 40 y ve +ve (aunt had global
developmental delay)
1st trimester
abortion twice
9 15 months F Full term Normal ve 27 y 45 y ve ve ve
12 4 months M Full term Normal ve 23 y 25 y ve +ve (aunt had polydactyly) ve
Table 8 Clinical and laboratory features of patients with 22q11.2 microdeletion.
No. Cardiac
defect
Extracardiac features Serum
calcium
CBC Thymus
shadow
on X-ray
2 PDA Microcephaly, brain atrophy, narrow palpebral
ﬁssure, epicanthus, depressed nasal bridge,
anteverted nostrils, microstomia, micrognathia,
low set posteriorly rotated ears, small vertical
diameter of the ears, recurrent episodes of
generalized seizures
Low Microcytic anemia
(Hb 7.3 g/dl)
Normal
6 VSD Normal mentality, delayed acquisition of motor
milestones but eventually normal. Hypertelorism,
a broad forehead, malar ﬂattening, epicanthic
fold, arched eyebrows, upward slanting palpebral
ﬁssure, hypoplastic ala nasi, delayed teething,
severe dental caries, micrognathia, attached ear
lobule, and posteriorly rotated ears
Low in
infancy
but
eventually
normal
Moderate
lymphopenia,
microcytic anemia
(Hb 10.3)
Normal
9 Double
outlet
right
ventricle
Delayed motor and mental milestones.
Microcephaly, brain atrophy, recurrent
generalized seizures, hypertelorism, slight
downward slanting palpebral ﬁssure, hooding of
the eyelids, mild parietal bossing, low set ears
with attached lobule, broad nasal bridge,
umbilical hernia, epigastric hernia, unilateral
simian crease, tapering ﬁngers, and
camptodactyly of the ﬁfth ﬁnger
Low Moderate
lymphopenia
Normal
12 PDA and
2 ASDs
Delayed motor and mental milestones,
microcephaly, brain atrophy, agenesis of the
corpus callosum, absent septum pellucidum.
Weight and length below the 3rd percentiles, anal
stenosis, laryngeal web (causing severe
obstruction), deep set eyes, triangular face, partial
synophrys, epicanthic fold, mild upward slanting
palpebral ﬁssure, anteverted nostrils, asymmetric
crying face, micrognathia, low set ears,
posteriorly rotated ears, skin tag on the right
helix, overriding toes (familial)
Normal Normocytic
anemia (Hb 9.5
g/dl)
Normal
PDA= patent ductus arteriosus.
VSD= ventricular septal defect.
ASD= atrial septal defect.
Chromosome 22 in syndromic congenital heart disease 317tip of a huge iceberg. Many physicians, if not most of them,
overlook non-cardiac congenital abnormalities in these pa-
tients. One of our aims was to participate in shedding light
on this speciﬁc population of patients with syndromic CHD.
In this context, we carefully examined all patients referred
for cardiac disease with the purpose of ﬁnding out any associ-ated extracardiac anomalies which warrant further evaluation
by high resolution karyotyping and FISH.
In our study, chromosomal aberrations were detected in 2
patients (10%) by high resolution banding. One of them had
a numerical aberration in the form of trisomy 13 (Patau
syndrome) and the other had a structural aberration (46,
Table 9 Prevalence of clinical and laboratory features in patients with 22q11.2 microdeletion.
Features present in
100% of cases
No
Features present in
75% of cases
Hypocalcemia in infancy, microcephaly, brain atrophy, epicanthus, low
set ears, micrognathia, posteriorly rotated ears, and anemia
Features present in
50% of cases
Delayed motor and mental milestones, upward slanting palpebral ﬁssure,
recurrent seizures, hypertelorism, attached ear lobule, anteverted nostrils,
PDA, and lymphopenia
Features present in 25% of cases
Growth Decreased weight and decreased length
Brain Agenesis of the corpus callosum, absent septum pellucidum
Heart DORV, VSD, ASD
Face Asymmetric crying face, malar ﬂattening, broad forehead, deep set eyes,
triangular face, partial synophrys
Ocular Hooding of the eyelids, antimongoloid slant, narrow palpebral ﬁssure,
arched eyebrows
Nose Broad nasal bridge, depressed nasal bridge, hypoplastic ala nasi
Ear Skin tag on the helix, short vertical diameter of ear
Abdomen Umbilical hernia, epigastric hernia, anal stenosis
Mouth Microstomia, dental caries, delayed teeth eruption
Larynx Laryngeal web
Hands and ﬁngers Simian crease, camptodactyly of 5th ﬁnger, tapering ﬁngers
Figure 1 (A) Photo of patient 3: Patau syndrome (47, XX,+13). (B) Photo of patient 5: 46,XY, add (13)(p13). Patient number 3 (Patau
syndrome: Fig. 1A) is a 10 day old full term female newborn. She is the 4th sibling of non-consanguineous marriage. The mother had a
history of recurrent spontaneous 1st trimester abortion (three times) and one ectopic pregnancy. There is no family history of CHD, other
congenital anomalies, or genetic diseases. Her weight and length are normal but the head circumference is just below the 3rd percentile.
She had several dysmorphic features including microcephaly, microphthalmia, narrow palpebral ﬁssure, arched eye brow, epicanthic folds,
prominent glabella, broad ﬂat nose, wide nasal bridge, long smooth philtrum, high arched palate, micrognathia, low set ear, loose skin on
the nape of the neck, post axial polydactyly, ﬂexed overlapped ﬁngers, and contractures at the elbows. She also had high pitched cry.
Echocardiography showed moderate ASD and VSD. Brain CT showed mild brain atrophy. This patient died at the age of 2.5 months due
to pneumonia and heart failure. Patient number 5 (Fig. 1B) [with 46,XY, add (13)(p13); Fig. 2) is a 1.5 year old male baby who is the 3rd
offspring of a non-consanguineous marriage. The baby was full term with normal birth weight. He had delayed motor milestones but
normal mental development. There was no family history of CHD but the ﬁrst sibling died at the age of 7 months as a result of CNS
infection and the parents were told by the physicians that the latter baby had a congenital lung anomaly and immune deﬁciency. Clinical
examination showed failure to thrive with weight, length, and head circumference below the 3rd percentiles. The extracardiac
abnormalities included microcephaly, frontal bossing, high arched palate, micrognathia, and low set ears. Echocardiography revealed
Tetralogy of Fallot. Total serum calcium was low (6.5 mg/dl). Absolute lymphocytic count was also low for age (2400 ml1).
318 S.S.A. El-Ella et al.XY, add (13) (p13). No chromosome 22 deletion was discov-
ered by high resolution banding.Many other studies have previously established a chromo-
somal origin of syndromic CHD. Elsobky et al. [16] found
Figure 2 Karyotyping of patient number 3: 47, XX,+13 (Patau
syndrome).
Figure 3 Karyotyping of patient number 5: 46,XY, add
(13)(p13).
Chromosome 22 in syndromic congenital heart disease 319chromosomal anomalies, by high resolution banding, in 37%
of a group of patients with syndromic CHD, including 3 pa-
tients with visible 22q11.2 deletion. Likewise, Soares et al.
[17] reported a prevalence of 26.1% for chromosomal anoma-
lies in patients with syndromic CHD.
The 22q11.2 deletion syndrome is one of the most fre-
quently recognized syndromes associated with CHD [18]. In
our study, 4 children (20%) were found to have 22q11.2 mic-
rodeletion by FISH technique. The prevalence of this microde-
letion in patients with syndromic CHD has varied among
studies. Consistent with our results, Bartsch et al. [19] reported
a prevalence of 19.7% in a series of 295 patients with suspected
DG/VCFS. Also, Elsobky et al. [16] detected 22q11.2 microde-
letion in 18.6% of patients with syndromic CHD. Other stud-
ies reported much lower prevalence. For example, Alikasifog˘lu
et al. [20] reported a prevalence of 6.9% for 22q11.2 deletion in
Turkish patients with syndromic conotruncal heart diseases.
On the other hand, some studies reported higher prevalence
rates. One such study is that of Soares et al. [17] who reported
a prevalence of 30.4% in a group of patients from Portugal
with CHD and other anomalies and patients with a phenotype
consistent with 22q11 microdeletion. The discrepancy among
these results might be explained in several ways including dif-
ferent ethnic backgrounds [21].
The pattern of congenital heart disease observed in our
22q11.2 deletion patients was unexpected. It included PDA,
VSD, ASD, and double outlet right ventricle (DORV).
Though VSD is one of the most common cardiac defects in
22q11.2 DS [22], DORV and ASD are among the least com-
mon [23,24] and isolated PDA is virtually one of the rare car-
diac lesions associated with 22q11.2 DS [25]. And although
Tetralogy of Fallot (TOF), is known to be the most common
cardiac malformation associated with 22q11.2 DS, occurring
in about 26% of cases [23], none of our patients with the mic-
rodeletion had this type of cardiac malformation.
How can these intriguing results be explained?
The small number of our study group is a possible explana-
tion and one may expect that a larger series would reveal
results more consistent with other larger studies. Another
explanation is the relative increase in the prevalence of ASD
and PDA (45% and 20% of total patients, respectively) com-
pared with Tetralogy of Fallot (10%) in the study population.However, it is logic to think of other factors such as ethnicity.
Ethnic differences are known to exist in terms of the relative
prevalence of congenital heart diseases [23]. For European pa-
tients with the 22q11.2 deletion, TOF with or without pulmon-
ary atresia was found in 27% [24]. However, among Japanese
patients with this syndrome, TOF with or without pulmonary
atresia was much more common (73%) [26]. The incidences of
cardiovascular anomalies among Korean patients with the
22q11.2 deletion are similar to those observed in Japan [25].
Anyhow, until further studies are conducted in this regard,
our results speak against the trend adopted by those centers
which screen for 22q11.2 deletion only in children with conotr-
uncal heart defects. It is thus prudent, as is the case in other
centers, to screen for 22q11.2 deletion among patients with
any type of congenital cardiac defects, whether or not conotr-
uncal especially if associated with other anomalies. In our
opinion, this may be the most signiﬁcant conclusion drawn
from this small study. We hope to help change the idea stuck
to 22q11.2 microdeletion as a syndrome linked only to speciﬁc
types of congenital heart defects.
In this study, many extracardiac features were found to be
associated with 22q11.2 microdeletion, the most frequent
among which were hypocalcemia, microcephaly, brain atro-
phy, epicanthus, low set ears, posteriorly rotated ears, micro-
gnathia, and anemia. The other features are enumerated in
Table 8. Most of these features have been reported to be asso-
ciated with 22q11.2 microdeletion [24,27–32].
Hypocalcemia was found in 3 of our four patients (75%)
with microdeletion. This is consistent with other authors
who reported the occurrence of hypocalcemia in a substantial
proportion of 22q11.2 microdeletion. For example, Kitsiou-
Tzeli et al. [33] found a prevalence of 47% for hypocalcemia
while Bassett et al. [34] reported a prevalence of 64%.
Seizures in 22q11.2 SD are usually, but not always, due to
hypocalcemia and it should be borne in mind that about 7% of
cases have unprovoked seizures [35]. Seizures were existent in 2
of our 4 (50%) patients with 22q11.2 deletion. Both of them
had the 2 potential causes of seizures, i.e. hypocalcemia and
brain atrophy.
Three of our four patients with 22 microdeletion had both
microcephaly and cerebral atrophy. This is consistentwithRyan
et al. [24] and Kobrynski and Sullivan [36], who reported that
Figure 4 Photos of the 4 patients with microdeletion 22q11.2.
Figure 5 Metaphase and interphase FISH of case 12 showing
absence, of the red signal in 1 chromosome 22 denoting microde-
letion [46, XY, ish del(22) (q11.2q11.2)(TUPLE1x1),
22q13(ARSAx2)].
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22q11.2 DS. As to microcephaly, Barnea-Goraly et al.[37] and
Campbell et al. [38] showed that it occurred in about 50% of
22q11.2 DS patients. Others showed that the prevalence of
microcephaly is only 10% [39]. In addition, two of our four
patients with 22 microdeletion had delayed motor and mental
development. This is consistent with many studies [40].
Laryngeal web was detected in one of our patients with 22
microdeletion (case 12). Laryngeal web had previously been
thought to be an uncommon association with 22 microdeletion,
but nearly two-thirds of the patients presenting with anterior
glottic webs were found to have the deletion. This identiﬁes an-
other subgroup for which screening is appropriate [41].
One of our patients had an anal abnormality in the form of
anal stenosis. This is consistent with Ryan et al. [24] who de-
tected anal abnormalities in 2% of their patients with
22q11.2 microdeletion, consisting of anal atresia, imperforate
anus, and anteriorly placed anus.
The majority of patients with 22q11.2 deletion syndrome
and immune defects exhibit mild to moderate deﬁcits in T-cell
counts [42]. In line with this fact, moderate lymphopenia was
detected in two of our patients with 22q11.2 microdeletion.
They experienced recurrent chest infections and had a normal
thymus size on X-ray. The presence of a normal thymic sha-
dow, by X-ray, in our patients with 22 microdeletion is not sur-
prising as, according to Sullivan [43], thymic hypoplasia is not
Chromosome 22 in syndromic congenital heart disease 321always directly visualized and diminished T-cell counts are of-
ten used as a surrogate. Also, Hussain [44] stated that although
chest radiographs may reveal an absence of a thymus shadow,
MRI is more reliable for estimating mediastinal thymus size.
Each year brings new information on the phenotypic spec-
trum of 22q11.2 deletion syndrome [45]. As far as we know, a
number of features, which were associated with 22q11.2 DS in
our study, have not been previously linked to that syndrome.
These included camptodactyly of the 5th ﬁnger, simian crease,
triangular face, arched eyebrows, broad forehead, deep set
eyes, and partial synophrys [46].
Individuals with 22q11DS may have mild phenotypes, so
marriage and reproduction are not uncommon [47]. This is
particularly true in one of our patients (patient no. 6) whose
phenotype is so mild especially after successful open heart sur-
gery for VSD. This makes genetic counseling very important in
this case. In the future, 50% of the offspring of this patient are
expected to inherit the same deletion. Unfortunately, the off-
spring are usually more severely affected than their parents
from whom they inherited the microdeletion [48]. In addition,
this particular patient has a special signiﬁcance: she had always
been deemed, by physicians, a case of isolated CHD based on
the normal motor and mental development and the absence of
other major congenital anomalies. It was only when she had
been examined by experienced dysmorphologists that she tran-
spired to have additional minor dysmorphic features which
warranted further genetic evaluation. This clearly stresses the
need for incorporating geneticists into the teams evaluating
all patients with CHD.
It is concluded that 22q11.2 microdeletion is a very
important etiology underlying syndromic CHD. This mic-
rodeletion should be looked for, by FISH technique, in all
such patients if their conventional karyotyping results are
normal especially those with hypocalcemia, microcephaly,
brain atrophy, epicanthus, low set ears, posteriorly rotated
ears, micrognathia, and anemia. However, the features of
the syndrome show marked variability and range from very
mild to severe or lethal. Consequently, screening for the 22
microdeletion should be performed in all children with syn-
dromic CHD even if the phenotype is subtle and whether
or not the type of CHD is conotruncal.References
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